Windtree Therapeutics Files 8-K on Financials and Listing Status
Ticker: WINTW · Form: 8-K · Filed: May 16, 2025 · CIK: 946486
| Field | Detail |
|---|---|
| Company | Windtree Therapeutics Inc /De/ (WINTW) |
| Form Type | 8-K |
| Filed Date | May 16, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, delisting-notice, exhibits
TL;DR
Windtree Therapeutics 8-K: Financials and potential delisting issues reported May 16, 2025.
AI Summary
Windtree Therapeutics, Inc. filed an 8-K on May 16, 2025, reporting on its results of operations and financial condition. The filing also addresses a notice of delisting or failure to satisfy a continued listing rule or standard, and includes financial statements and exhibits. The company was formerly known as Discovery Laboratories Inc. /DE/.
Why It Matters
This filing provides crucial updates on Windtree Therapeutics' financial health and its compliance with stock exchange listing requirements, which could impact its stock trading status.
Risk Assessment
Risk Level: medium — The filing mentions a notice of delisting or failure to satisfy a continued listing rule, indicating potential risks to the company's stock trading.
Key Players & Entities
- Windtree Therapeutics, Inc. (company) — Registrant
- Discovery Laboratories Inc. /DE/ (company) — Former company name
- May 16, 2025 (date) — Date of earliest event reported
FAQ
What is the primary reason for Windtree Therapeutics filing this 8-K?
Windtree Therapeutics filed this 8-K to report on its results of operations and financial condition, as well as to provide a notice of delisting or failure to satisfy a continued listing rule or standard.
What was Windtree Therapeutics' former company name?
Windtree Therapeutics, Inc. was formerly known as Discovery Laboratories Inc. /DE/.
On what date was this 8-K filing reported?
The earliest event reported in this 8-K filing was on May 16, 2025.
What specific items are included in this 8-K filing?
This 8-K filing includes information on Results of Operations and Financial Condition, a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard, and Financial Statements and Exhibits.
In which state was Windtree Therapeutics incorporated?
Windtree Therapeutics, Inc. was incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 16, 2025 regarding WINDTREE THERAPEUTICS INC /DE/ (WINTW).